Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $110.2600 (1.89%) ($108.3600 - $110.3600) on Mon. Mar. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.39% (three month average) | RSI | 64 | Latest Price | $110.2600(1.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.8% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(45%) SPLV(36%) VYM(32%) XLP(32%) DIA(30%) | Factors Impacting ABBV price | ABBV will decline at least -0.695% in a week (0% probabilities). VIXM(-21%) UUP(-10%) VXX(-3%) TLT(-1%) KWEB(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.695% (StdDev 1.39%) | Hourly BBV | 1.5 () | Intraday Trend | 1.5% | | | |
|
5 Day Moving Average | $108.23(1.88%) | 10 Day Moving Average | $107.47(2.6%) | 20 Day Moving Average | $107.11(2.94%) | To recent high | -2.1% | To recent low | 7.8% | Market Cap | $194.53b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |